Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Okyo Pharma Limited (OKYO.LN)

Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
R&D Activities for Treating Dry Eye Syndrome Resulting in Promising Pipeline of Treatments FinancialNewsMedia - Tue May 2, 2023

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:NVS),(NASDAQ:ALDX),(NASDAQ:OCUL),(NASDAQ:EYPT) EQNX::TICKER_END

ALDX : 1.5500 (-2.52%)
OKYO : 1.4900 (-2.93%)
EYPT : 13.89 (+8.26%)
NVS : 156.33 (+1.37%)
OKYO.LN : 1.400 (-24.32%)
OCUL : 9.19 (+5.15%)
Wall Street - NYSE Stock Market American Flag
Stocks Climb Before the Open as Investors Weigh Economic Outlook, U.S. JOLTs Report in Focus Barchart - Tue Apr 4, 2023

June S&P 500 futures (ESM23) are up +0.29%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.61% this morning after three major U.S. benchmark indices finished the regular session mixed as weaker-than-expected...

VORB : 0.0769 (-34.83%)
ESM23 : 4,453.35s (+0.61%)
TSLA : 328.58 (+2.83%)
ONCT : 0.5266 (-24.11%)
AMC : 2.59 (+0.78%)
NQM23 : 15,316.61s (+0.85%)
HLN : 10.03 (unch)
CRBG : 33.68 (-0.97%)
OKYO.LN : 1.400 (-24.32%)
BFLY : 8.83 (+6.39%)
EVO : 2.00 (+2.56%)
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm Business Wire - Tue Aug 30, 2022

OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, plans a Q4 2022...

OKYO : 1.4900 (-2.93%)
OKYO.LN : 1.400 (-24.32%)

Barchart Exclusives

Apple's Favorite Bullying Tactic Just Died in China. It Could Cost You Hundreds on Your Next iPhone. Barchart - Sun Aug 9, 4:06PM CDT
Rising memory demand has shifted pricing power away from Apple, giving Micron and other memory makers a stronger negotiating position. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.